SMTL ID : 7uso.1

Crystal Structure of Caspase-3 with Peptide Inhibitor AcITVKD-CHO

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

hetero-2-2-mer

Ligands

2 x ACE- ILE- THR- VAL- LYS- ASP: Peptide Inhibitor AcITVKD-CHO(Non-covalent)

ACE-ILE-THR-VAL-LYS-ASP.1: 17 residues within 4Å: Chain A: R.36, S.92, H.93, G.94, Q.133, C.135 Chain B: Y.29, S.30, W.31, R.32, N.33, S.34, W.39, S.74, F.75, F.77, F.81 25 PLIP interactions: 19 interactions with chain B, 6 interactions with chain A Hydrophobic interactions: B:Y.29, B:Y.29, B:W.31, B:W.31, B:W.39, B:F.77, B:F.77, B:F.81 Hydrogen bonds: B:Y.29, B:S.30, B:R.32, B:R.32, B:R.32, B:N.33, B:S.34, B:S.34, B:F.75, B:F.75, A:G.94, A:G.94, A:Q.133, A:C.135 Salt bridges: B:R.32, A:R.36, A:H.93 ACE-ILE-THR-VAL-LYS-ASP.2: 16 residues within 4Å: Chain C: R.36, S.92, H.93, G.94, Q.133, C.135 Chain D: Y.29, S.30, W.31, R.32, N.33, S.34, W.39, S.74, F.75, F.81 20 PLIP interactions: 16 interactions with chain D, 4 interactions with chain C Hydrophobic interactions: D:Y.29, D:Y.29, D:W.31, D:W.31, D:W.39, D:F.75 Hydrogen bonds: D:S.30, D:R.32, D:R.32, D:R.32, D:N.33, D:S.34, D:F.75, D:F.75, D:F.75, C:G.94, C:Q.133, C:C.135 Salt bridges: D:R.32, C:R.36

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bresinsky, M. et al., Characterization of caspase-2 inhibitors based on specific sites of caspase-2-mediated proteolysis. Arch Pharm (2022)

Release Date

2022-06-01

Peptides

Caspase-3 subunit p17: AC
Caspase-3 subunit p12: BD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
C

B
B

D
D

Caspase-3 subunit p17

Caspase-3 subunit p12

Related Entries With Identical Sequence